| Biologic Therapy |
0 |
0.95 |
| CAR-T |
0 |
0.99 |
| Acute Leukemia |
0 |
0.68 |
| T-Lymphocyte |
0 |
0.47 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Toxicology |
0 |
0.34 |
| Social Determinants of Health |
0 |
0.29 |
| Acute Lymphoblastic Leukemia |
0 |
1 |
| Arrhythmia |
0 |
0.25 |
| Pain Management |
0 |
0.25 |
| Health Care Quality, Access, and Evaluation |
0 |
0.23 |
| Leukemia |
0 |
0.23 |
| Remission |
0 |
0.23 |
| Constipation |
0 |
0.15 |
| Diarrhea |
0 |
0.15 |
| Headache |
0 |
0.15 |
| Lysosomal Storage Disease |
0 |
0.15 |
| Neutropenia |
0 |
0.15 |
| Antigens |
0 |
0.12 |
| Brachial |
0 |
0.12 |
| Cancer |
0 |
0.12 |
| Chemotherapy |
0 |
0.12 |
| Child |
0 |
0.12 |
| Cytokines |
0 |
0.12 |
| Edema |
0 |
0.12 |
| Encephalopathy |
0 |
0.12 |
| Fatigue |
0 |
0.12 |
| Fever |
0 |
0.12 |
| Florida |
0 |
0.12 |
| Hypotension |
0 |
0.12 |
| Hypoxia |
0 |
0.12 |
| I-Cell Disease |
0 |
0.12 |
| Lymphoma |
0 |
0.12 |
| Nausea |
0 |
0.12 |
| Pain |
0 |
0.12 |
| Prognosis |
0 |
0.12 |
| Receptors |
0 |
0.12 |
| Refractory |
0 |
0.12 |
| Tachycardia |
0 |
0.12 |
| Tremor |
0 |
0.12 |